allied
academies
CANCER STEM CELLS AND
ONCOLOGY RESEARCH
11
th
International Conference on
J u n e 1 1 - 1 3 , 2 0 1 8 | D u b l i n , I r e l a n d
Journal of Medical Oncology and Therapeutics
|
Volume 3
Page 18
Note:
I
dentification of cancer stem cells (CSC) in solid tumours – with
self-renewal, multipotency, tumorigenesis, and therapy resistance
capacities – has opened path to new targeting therapeutic approaches.
However, CSC targeting alone might not be sufficient to eradicate a
tumour. Indeed, recent studies showed that cancer cells are plastic,
and conventional therapies, such as radiotherapy, can lead to cancer
cells (non-CSC) reprogramming into iCSC (induced-CSC). The goal
of our work is to identify the molecular mechanisms responsible
for treatment-induced CSC emergence. First, we have shown that
conditioned media from irradiated non-CSC is sufficient to induce iCSC
reprogramming. These results suggest that cell plasticity might be
actively regulated by diffusible factors secreted by irradiated cells. By
using proteins arrays and ELISA, we demonstrated that the secretion
of a specific cocktail of chemokines is induced by ionizing radiation,
such as CXCL1 and CCL5. Interestingly, recombinant CXCL1 and CCL5
treatments increase the sphere forming capacity (SFC) of isolated non-
CSC treated population. Concomitantly, treatment with neutralizing
antibodies targeting CXCL1 and CCL5 leads to a decreased CSC number
(ALDH+ cells). Most importantly, treatment with neutralising antibodies
through radiation treatment of xenograft in SCID mice double the
survival time of the mice. Preclinical study show predictive value of
CXCL1 and CCL5 expression. We also studied the expression of the
corresponding chemokines receptors, by flow cytometry. First, we saw
that reprogrammable ALDH- cells are enriched for CXCL1 and CCL5
receptors expressing cells compare to unsorted population or ALDH+
population (CSC). We analysed the reprogramming potential of isolated
ALDH-/receptor-positive cells versus ALDH-/receptor-negative cells.
The ALDH-/receptor-positive-derived cell population is more able to
form spheres and overcomes the receptor-negative-derived population
when the two populations are mixed and tested for their sphere forming
capacity. The use of pharmacological inhibitors against the receptors
induce a slight decrease of CSC. Taken together, our results indicate
the involvement of chemokines, in particular CXCL1 and CCL5, in the
reprogramming mechanism.
Biography
Chann Lagadec has spent five years as a Post-
doctoral fellowship in Dr. Pajonk’lab, a pioneer in
CSC research field. Within the time at UCLA in the
Radiation Oncology Department, he got trained in
CSC and was the first to demonstrate the pheno-
type plasticity of CSC induced by radiation treat-
ment. Since 2012, he set up his own team in the
INSERM U908 lab in Lille, France, where he stud-
ies the molecular mechanisms involved in the
reprogramming process. He develops molecular
tools and an animal model to track and charac-
terize CSC and iCSC. His domain of interest en-
larges recently to understand the potential role of
reprogramming in tumor dormancy andmetasta-
sis development.
chann.lagadec@inserm.frINFLAMMATORY CYTOKINES,
INDUCED BY IONIZING RADIATION,
REPROGRAM NON-TUMORIGENIC
CANCER CELLS INTO CANCER
STEM CELLS IN BREAST CANCER
Chann Lagadec
INSERM, France
Chann Lagadec, J Med Oncl Ther 2018, Volume 3